Pharvaris
PHVS
54 hedge funds and large institutions have $856M invested in Pharvaris in 2024 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 19 increasing their positions, 12 reducing their positions, and 6 closing their positions.
58% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 12
50% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 6
6% more funds holding
Funds holding: 51 → 54 (+3)
3% more capital invested
Capital invested by funds: $834M → $856M (+$21.6M)
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
0.74% less ownership
Funds ownership: 83.4% → 82.66% (-0.74%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$4.46M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$3.91M |
| 3 |
OCA
Octagon Capital Advisors
New York
|
+$3.24M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$2.44M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$1.57M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
-$16.7M |
| 2 |
VA
VR Adviser
New York
|
-$3.61M |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$1.09M |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$1.05M |
| 5 |
SI
Sofinnova Investments
Menlo Park,
California
|
-$815K |
PHVS Hedge Fund Activity: Q4 2024 in Review
54 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Pharvaris (PHVS) for Q4 2024, worth a combined $856M — up 2.6% from $834M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new PHVS positions and 6 closed out — a net gain of 3 holders — while 19 added to existing stakes and 12 trimmed.
The largest buyer was Soleus Capital Management, adding an estimated $4.46M. The largest seller was EcoR1 Capital, exiting entirely with an estimated $16.7M sold.
- 54 institutional investors held Pharvaris (PHVS) as of Q4 2024, up from 51 in Q3 2024.
- Funds reported $856M of Pharvaris stock for Q4 2024, up 2.6% quarter-over-quarter.
- 9 funds opened new Pharvaris positions in Q4 2024 and 6 closed out, a net change of +3 holders.
- The largest Pharvaris buyer in Q4 2024 was Soleus Capital Management, an estimated $4.46M added.
- The largest Pharvaris seller in Q4 2024 was EcoR1 Capital, an estimated $16.7M sold.
Based on aggregated 13F filings for Q4 2024.